Last update 01 Nov 2024
Jiangsu Dekang Biotechnology Co. Ltd.

Jiangsu Dekang Biotechnology Co. Ltd.

Subsidiary Company|
2013|
Jiangsu Sheng, China

Overview

Tags

Digestive System Disorders
Other Diseases
Mesenchymal stem cell therapy

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Top 5 Drug TypeCount
Mesenchymal stem cell therapy1

Related

1
Drugs associated with Jiangsu Dekang Biotechnology Co. Ltd.
Adipose derived MSC cell (Jiangsu Dekang Biotechnology)
Target-
Mechanism
Cell replacements
Active Org.
Jiangsu Dekang Biotechnology Co. Ltd.Jiangsu Dekang Biotechnology Co. Ltd.
Originator Org.
Jiangsu Dekang Biotechnology Co. Ltd.Jiangsu Dekang Biotechnology Co. Ltd.
Active Indication
Crohn Disease [+1]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Jiangsu Dekang Biotechnology Co. Ltd.
CTR20213380 / Active, not recruitingPhase 1/2
DK001治疗克罗恩病的复杂性肛瘘的安全性、耐受性和初步有效性的I/II期临床试验
[Translation] Phase I/II clinical trial of the safety, tolerability and preliminary efficacy of DK001 in the treatment of complex anal fistulas in Crohn's disease
100 Clinical Results associated with Jiangsu Dekang Biotechnology Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Jiangsu Dekang Biotechnology Co. Ltd.
Login to view more data
100 Deals associated with Jiangsu Dekang Biotechnology Co. Ltd.
Login to view more data
100 Translational Medicine associated with Jiangsu Dekang Biotechnology Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Adipose derived MSC cell (Jiangsu Dekang Biotechnology)
Perianal fistula
More
Phase 2 Clinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free